Aleksey V. Buhler

Aleksey V. Buhler

Auto-generated profile, based on publicly available information

Aleksey V. Buhler

Institute of Natural Sciences and Mathematics, Ural Federal University, Ekaterinburg 620075, Russia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2024 in Metabolites
Verified
Journal Article
Open access
PDF file
EDEkaterina Demicheva
Ekaterina Demicheva
Vladislav DordiukVladislav Dordiuk
Vladislav Dordiuk
FEFernando Jonathan Polanco Espino
Fernando Jonathan Polanco Espino
KUKonstantin Ushenin
Konstantin Ushenin
SASaied A Aboushanab
Saied A Aboushanab
EKElena Germanovna Kovaleva
Elena Germanovna Kovaleva
Blood metabolomics profiling using mass spectrometry has emerged as a powerful approach for investigating non-cancer diseases and understanding their underlying metabolic alterations. Blood, as a readily accessible physiological fluid, contains a diverse repertoire of metabolites derived from various physiological systems. Mass spectrometry offers a universal and precise analytical platform for the comprehensive analysis of blood metabolites, encompassing proteins, lipids, peptides, glycans, and immunoglobulins. In this comprehensive review, we present an overview of the research landscape in mass spectrometry-based blood metabolomics profiling. While the field of metabolomics research is primarily focused on cancer, this review specifically highlights studies related to non-cancer diseases, aiming to bring attention to valuable research that often remains overshadowed. Employing natural language processing methods, we processed 507 articles to provide insights into the application of metabolomic studies for specific diseases and physiological systems. The review encompasses a wide range of non-cancer diseases, with emphasis on cardiovascular disease, reproductive disease, diabetes, inflammation, and immunodeficiency states. By analyzing blood samples, researchers gain valuable insights into the metabolic perturbations associated with these diseases, potentially leading to the identification of novel biomarkers and the development of personalized therapeutic approaches. Furthermore, we provide a comprehensive overview of various mass spectrometry approaches utilized in blood metabolomics research, including GC-MS, LC-MS, and others discussing their advantages and limitations. To enhance the scope, we propose including recent review articles supporting the applicability of GC×GC-MS for metabolomics-based studies. This addition will contribute to a more exhaustive understanding of the available analytical techniques. The Integration of mass spectrometry-based blood profiling into clinical practice holds promise for improving disease diagnosis, treatment monitoring, and patient outcomes. By unraveling the complex metabolic alterations associated with non-cancer diseases, researchers and healthcare professionals can pave the way for precision medicine and personalized therapeutic interventions. Continuous advancements in mass spectrometry technology and data analysis methods will further enhance the potential of blood metabolomics profiling in non-cancer diseases, facilitating its translation from the laboratory to routine clinical application.

Verified
Journal Article
Open access
PDF file
VTVADIM Tseilikman
VADIM Tseilikman
JFJulia Fedotova
Julia Fedotova
OTOlga B. Tseilikman
Olga B. Tseilikman
JNJurica Novak
Jurica Novak
MKMarina Karpenko
Marina Karpenko
EKElena Germanovna Kovaleva
Elena Germanovna Kovaleva
Glucocorticoids are metabolized by the CYP3A isoform of cytochrome P450 and by 11-β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1). Experimental data suggest that post-traumatic stress disorder (PTSD) is associated with an increase in hepatic 11β-HSD-1 activity and a concomitant decrease in hepatic CYP3A activity. Trans-resveratrol, a natural polyphenol, has been extensively studied for its antipsychiatric properties. Recently, protective effects of trans-resveratrol were found in relation to PTSD. Treatment of PTSD rats with trans-resveratrol allowed the rats to be divided into two phenotypes. The first phenotype is treatment-sensitive rats (TSR), and the second phenotype is treatment-resistant rats (TRRs). In TSR rats, trans-resveratrol ameliorated anxiety-like behavior and reversed plasma corticosterone concentration abnormalities. In contrast, in TRR rats, trans-resveratrol aggravated anxiety-like behavior and decreased plasma corticosterone concentration. In TSR rats, hepatic 11β-HSD-1 activity was suppressed, with a concomitant increase in CYP3A activity. In TRR rats, the activities of both enzymes were suppressed. Thus, the resistance of PTSD rats to trans-resveratrol treatment is associated with abnormalities in hepatic metabolism of glucocorticoids. The free energy of binding of resveratrol, cortisol, and corticosterone to the human CYP3A protein was determined using the molecular mechanics Poisson–Boltzmann surface area approach, indicating that resveratrol could affect CYP3A activity.

Verified
Journal Article
Open access
PDF file
VTVADIM Tseilikman
VADIM Tseilikman
VSVladislav A. Shatilov
Vladislav A. Shatilov
MZMaxim S. Zhukov
Maxim S. Zhukov
IBIrina A. Buksha
Irina A. Buksha
AEAlexandr E. Epitashvily
Alexandr E. Epitashvily
OTOlga B. Tseilikman
Olga B. Tseilikman
Currently, the efficacy of drug therapy for post-traumatic stress disorder or PTSD leaves much to be desired, making nutraceutical support a promising avenue for treatment. Recent research has identified the protective effects of resveratrol in PTSD. Here, we tested the behavioral and neurobiological effects of combining cheese consumption with resveratrol supplements in an experimental PTSD model. Using the elevated plus maze test, we observed that cheese intake resulted in a shift from anxiety-like behavior to depressive behavior, evident in increased freezing acts. However, no significant changes in the anxiety index value were observed. Interestingly, supplementation with cheese and resveratrol only led to the elimination of freezing behavior in half of the PTSD rats. We further segregated the rats into two groups based on freezing behavior: Freezing+ and Freezing0 phenotypes. Resveratrol ameliorated the abnormalities in Monoamine Oxidize -A and Brain-Derived Neurotrophic Factor gene expression in the hippocampus, but only in the Freezing0 rats. Moreover, a negative correlation was found between the number of freezing acts and the levels of Monoamine Oxidize-A and Brain-Derived Neurotrophic Factor mRNAs in the hippocampus. The study results show promise for resveratrol supplementation in PTSD treatment. Further research is warranted to better understand the underlying mechanisms and optimize the potential benefits of resveratrol supplementation for PTSD.

31 August 2025 in Siberian Journal of Life Sciences and Agriculture
Verified
Journal Article
Open access
PDF file
PVPavel Vedeneev
Pavel Vedeneev
ABAleksey V. Buhler
Aleksey V. Buhler
ILIrina A. Lebedeva
Irina A. Lebedeva
EKElena Germanovna Kovaleva
Elena Germanovna Kovaleva
The problem of antibiotic resistance is more relevant than ever. The crisis associated with the spread of resistance to antibiotics is approaching every day. New antibacterial drugs and methods that allow for effective combating of resistant microorganisms are not emerging, therefore posing a serious challenge to humanity, as the effectiveness of antibiotics directly impacts important areas of human life such as medicine and agriculture. Purpose. The article provides a systematic view of the phenomenon of antibiotic resistance. Materials and methods.To analyze the literature, materials from the PubMed and PubMed Central resources of the US National Library of Medicine, Google Scholar, Elsevier Clinical Key and Elsevier Science Direct. The sample consisted of scientific papers devoted to antibiotic resistance. Results.The article reveals the causes of emergence, mechanisms, rate of development, pathways of spread of antibiotic resistance and consequences of acquiring resistance for microorganisms and methods of containing antibiotic resistance.

1 January 2024 in Bulletin of the South Ural State University. Series Food and Biotechnology
Verified
Journal Article
Open access
PDF file
MKMustapha Mohab Kamel
Mustapha Mohab Kamel
EKElena Germanovna Kovaleva
Elena Germanovna Kovaleva
ABAlexey V. Buhler
Alexey V. Buhler
The objective of this work is to analyze the cheese amino acid profile through the ripening period. The evaluation of the effect of Para-aminobenzoic acid (PABA) on the proteolytic activity of Lactococcus lactis subsp. lactis, Lactococcus lactis subsp. cremoris, and Streptococcus salivarius subsp. thermophilus, allows to deduce their vitality during the ripening period within 28 days. Four cheeses have been prepared and analyzed (a) control cheese, (b) cheese with 0.1 g/l PABA, (c) cheese with 0.2 g/l PABA and (d) cheese with 0.4 g/l PABA – in two stages: t0 (beginning of ripening period) and t1 (end of ripening period). The protein content was measured by Kjeldahl method and the amino acid profile was done by High-Performance Liquid Chromatography (HPLC). In the cheeses with 0.1 and 0.2 g/liter (PABA), significantly higher contents of most amino acids were measured compared to those for the control cheese. In the cheese samples with 0.4 g/liter PABA all amino acids were significantly higher in quantity than those in the control cheese.

16 January 2025 in Metabolites
Verified
Journal Article
Open access
PDF file
EDEkaterina Demicheva
Ekaterina Demicheva
FEFernando Jonathan Polanco Espino
Fernando Jonathan Polanco Espino
PVPavel Vedeneev
Pavel Vedeneev
VSVadim A. Shevyrin
Vadim A. Shevyrin
ABAleksey Buhler
Aleksey Buhler
EKElena Germanovna Kovaleva
Elena Germanovna Kovaleva
Purpose: Immunodeficiency conditions, which are characterized by reduced immune activity that promotes the development of chronic diseases, are needed for efficient monitoring. A promising area of monitoring and early diagnosis of immunodeficiency diseases is the determination of metabolic biomarkers in the blood. Methods: In this work, we identified a set of lipid biomarkers of immunodeficiency states by performing high-performance liquid chromatography–high-resolution mass spectrometry (HPLC-HRMS) analysis of blood plasma samples from mice and processing them with bioinformatics approaches. Potential biomarkers were selected through statistical analysis and further validated by MS/MS. Conclusions: As a result, 15 lipids were confirmed and selected as potential biomarkers of immunodeficiency states. The selected biomarkers can be further studied and serve as promising targets for the early diagnosis of immunodeficiency diseases.